Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-23 4:40 pm Purchase | 2023-10-13 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital, LP | 248,925 5.800% | 248,925 (New Position) | Filing History |
| 2023-10-02 4:32 pm Purchase | 2023-09-22 | 13G | AnaptysBio, Inc. ANAB | Deep Track Capital, LP | 1,360,176 5.120% | 1,360,176 (New Position) | Filing History |
| 2023-09-29 4:15 pm Purchase | 2023-09-20 | 13G | HilleVax, Inc. HLVX | Deep Track Capital, LP | 2,900,000 6.140% | 2,900,000 (New Position) | Filing History |
| 2023-08-04 4:17 pm Purchase | 2023-07-26 | 13G | Editas Medicine, Inc. EDIT | Deep Track Capital, LP | 4,493,416 5.510% | 4,493,416 (New Position) | Filing History |
| 2023-07-28 4:25 pm Purchase | 2023-07-20 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 3,560,000 6.280% | 3,560,000 (New Position) | Filing History |
| 2023-07-24 4:05 pm Purchase | 2023-07-14 | 13G | Apogee Therapeutics, Inc. APGE | Deep Track Capital, LP | 3,023,456 8.870% | 3,023,456 (New Position) | Filing History |
| 2023-06-30 4:00 pm Purchase | 2023-06-22 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Deep Track Capital, LP | 290,322 9.990% | 290,322 (New Position) | Filing History |
| 2023-06-15 4:02 pm Purchase | 2023-06-05 | 13G | Zura Bio Limited ZURA | Deep Track Capital, LP | 4,205,000 9.390% | 4,205,000 (New Position) | Filing History |
| 2023-05-19 4:23 pm Purchase | 2023-05-11 | 13G | Dynavax Technologies Corporation DVAX | Deep Track Capital, LP | 6,556,180 5.100% | 6,556,180 (New Position) | Filing History |
| 2023-04-14 4:35 pm Purchase | 2023-04-04 | 13G | SpringWorks Therapeutics, Inc. SWTX | Deep Track Capital, LP | 3,254,132 5.210% | 3,254,132 (New Position) | Filing History |
| 2023-04-14 4:34 pm Purchase | 2023-04-04 | 13G | Nektar Therapeutics NKTR | Deep Track Capital, LP | 820,149 6.500% | 820,149 (New Position) | Filing History |
| 2023-03-20 4:55 pm Purchase | 2023-03-10 | 13G | Pliant Therapeutics, Inc. PLRX | Deep Track Capital, LP | 3,104,507 5.270% | 3,104,507 (New Position) | Filing History |
| 2023-03-20 4:43 pm Purchase | 2023-03-10 | 13G | Orchard Therapeutics plc ORTX | Deep Track Capital, LP | 19,125,150 9.990% | 19,125,150 (New Position) | Filing History |
| 2023-02-24 4:13 pm Purchase | 2023-02-16 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,717,171 5.750% | 450,602 (+19.88%) | Filing History |
| 2023-02-14 09:53 am Sale | 2022-12-31 | 13G | Keros Therapeutics, Inc. KROS | Deep Track Capital, LP | 0 0.000% | -1,300,000 (Position Closed) | Filing History |
| 2023-02-14 08:59 am Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Deep Track Capital, LP | 3,312,974 7.930% | 1,493,285 (+82.06%) | Filing History |
| 2023-02-14 08:59 am Purchase | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 4,582,000 7.140% | 1,146,800 (+33.38%) | Filing History |
| 2023-02-14 08:58 am Sale | 2022-12-31 | 13G | TRICIDA INC TCDAQ | Deep Track Capital, LP | 4,666,666 7.440% | -1,191,163 (-20.33%) | Filing History |
| 2023-02-14 08:57 am Purchase | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital, LP | 2,727,606 6.500% | 627,606 (+29.89%) | Filing History |
| 2023-02-14 08:56 am Purchase | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital, LP | 2,837,818 9.430% | 356,818 (+14.38%) | Filing History |